Skip Navigation LinksHome > June 2011 - Volume 54 - Issue 2 > Recurrent Endometrial Cancer
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e318218c6d1
Endometrial Cancer

Recurrent Endometrial Cancer

DEL CARMEN, MARCELA G. MD, MPH; BORUTA, DAVID M. II MD; SCHORGE, JOHN O. MD

Collapse Box

Abstract

Endometrial cancer is the most common gynecologic malignancy in the United States. The majority of women are diagnosed with early-stage, low-grade endometrioid tumors that are highly curable with primary surgery. Patients with more advanced and/or higher grade disease require multimodality therapy and have a higher risk for recurrence. Although uterine papillary serous carcinoma and clear cell carcinoma are diagnosed infrequently, they account for almost half of all relapses. As women with recurrent endometrial cancer constitute a heterogeneous group, an individualized approach is required. We review the treatment options of surgery, radiation, hormonal therapy, cytotoxic chemotherapy, and biological agents.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.